Multivariable analysis (MVA) for OS for TS population can be seen in Table 3. Age (p < 0.0001, HR = 1.029) and male sex (p < 0.0001, HR = 1.453) were significantly associated with OS. OS was significantly better than Whites (HR = 0.693–0.843) in all groups except for AI/ANs, Japanese, Blacks, and Hispanics who had a similar OS. MVA-adjusted OS by ethic group can be seen in Figure 1B. As compared to Connecticut, worse survival was noted in California, Greater Georgia, Iowa, Kentucky, Louisiana, and Utah. OS was not income dependent. Insured patients had a better OS than those on Medicaid (p < 0.0001, HR = 1.286). Married patients had a better OS than divorced (p < 0.0001, HR = 1.191), widowed (p < 0.0001, HR = 1.229), and single patients (p < 0.0001, HR = 1.1215). As compared to Stage I, Stages II–IV were associated with a worse OS with a progressively increasing HR (all p < 0.0001, HR = 1.702–3.273). As compared to patients with adenocarcinoma, all histologies were associated with a worse OS (p < 0.0001 to <0.0008, HR = 1.119–1.564). Using well-differentiated tumors as a reference, all other tumor grades were associated with a worse OS (all p < 0.0001, HR = 1.665–3.273). Segmentectomies and (bi)lobectomies were associated with a better OS than pneumonectomies, p = 0.0011, HR = 0.80; p < 0.0001, HR = 0.72, respectively. Patients who received radiation (p < 0.0001, HR = 1.162) experienced worse OS. Number of nodes examined was associated with better OS (p < 0.0001, HR = 0.988), but number of nodes positive (p < 0.0001, HR = 1.04) and lymph node density (p < 0.0001, HR = 1.429) were associated with worse OS. Compared to year 2007, those patients diagnosed in 2010–2012 had significantly better OS with progressively decreasing hazard ratios. OS by insurance status can be seen in Figure 2.